annual CFO:
-$109.03M-$17.08M(-18.58%)Summary
- As of today (July 6, 2025), EWTX annual cash flow from operations is -$109.03 million, with the most recent change of -$17.08 million (-18.58%) on December 31, 2024.
- During the last 3 years, EWTX annual CFO has fallen by -$75.52 million (-225.39%).
- EWTX annual CFO is now -1088.83% below its all-time high of -$9.17 million, reached on December 31, 2019.
Performance
EWTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$37.87M-$10.91M(-40.47%)Summary
- As of today (July 6, 2025), EWTX quarterly cash flow from operations is -$37.87 million, with the most recent change of -$10.91 million (-40.47%) on March 31, 2025.
- Over the past year, EWTX quarterly CFO has dropped by -$9.27 million (-32.41%).
- EWTX quarterly CFO is now -1282.48% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$118.30M-$9.27M(-8.50%)Summary
- As of today (July 6, 2025), EWTX TTM cash flow from operations is -$118.30 million, with the most recent change of -$9.27 million (-8.50%) on March 31, 2025.
- Over the past year, EWTX TTM CFO has dropped by -$20.58 million (-21.06%).
- EWTX TTM CFO is now -4218.95% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EWTX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.6% | -32.4% | -21.1% |
| 3 y3 years | -225.4% | -201.2% | -195.6% |
| 5 y5 years | -1088.8% | -1282.5% | -1659.3% |
EWTX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -225.4% | at low | -219.4% | at low | -154.4% | at low |
| 5 y | 5-year | -1088.8% | at low | -1057.3% | at low | -1659.3% | at low |
| alltime | all time | -1088.8% | at low | -1282.5% | at low | -4218.9% | at low |
EWTX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$37.87M(+40.5%) | -$118.30M(+8.5%) |
| Dec 2024 | -$109.03M(+18.6%) | -$26.96M(-1.5%) | -$109.03M(+0.1%) |
| Sep 2024 | - | -$27.37M(+4.9%) | -$108.90M(+5.1%) |
| Jun 2024 | - | -$26.10M(-8.7%) | -$103.58M(+6.0%) |
| Mar 2024 | - | -$28.60M(+6.6%) | -$97.72M(+6.3%) |
| Dec 2023 | -$91.95M(+74.7%) | -$26.83M(+21.6%) | -$91.95M(+19.5%) |
| Sep 2023 | - | -$22.06M(+9.0%) | -$76.97M(+15.1%) |
| Jun 2023 | - | -$20.23M(-11.4%) | -$66.88M(+6.3%) |
| Mar 2023 | - | -$22.83M(+92.5%) | -$62.89M(+19.5%) |
| Dec 2022 | -$52.63M | -$11.86M(-0.9%) | -$52.63M(+4.9%) |
| Sep 2022 | - | -$11.96M(-26.4%) | -$50.20M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$16.25M(+29.2%) | -$46.50M(+16.2%) |
| Mar 2022 | - | -$12.57M(+33.5%) | -$40.02M(+19.4%) |
| Dec 2021 | -$33.51M(+129.0%) | -$9.42M(+14.0%) | -$33.51M(+16.6%) |
| Sep 2021 | - | -$8.26M(-15.4%) | -$28.73M(+21.0%) |
| Jun 2021 | - | -$9.77M(+61.3%) | -$23.74M(+32.2%) |
| Mar 2021 | - | -$6.06M(+30.6%) | -$17.95M(+22.7%) |
| Dec 2020 | -$14.63M(+59.6%) | -$4.64M(+41.7%) | -$14.63M(+46.4%) |
| Sep 2020 | - | -$3.27M(-17.9%) | -$10.00M(+48.7%) |
| Jun 2020 | - | -$3.98M(+45.5%) | -$6.72M(+145.5%) |
| Mar 2020 | - | -$2.74M | -$2.74M |
| Dec 2019 | -$9.17M | - | - |
FAQ
- What is Edgewise Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual CFO year-on-year change?
- What is Edgewise Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly CFO year-on-year change?
- What is Edgewise Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM CFO year-on-year change?
What is Edgewise Therapeutics annual cash flow from operations?
The current annual CFO of EWTX is -$109.03M
What is the all time high annual CFO for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual cash flow from operations is -$9.17M
What is Edgewise Therapeutics annual CFO year-on-year change?
Over the past year, EWTX annual cash flow from operations has changed by -$17.08M (-18.58%)
What is Edgewise Therapeutics quarterly cash flow from operations?
The current quarterly CFO of EWTX is -$37.87M
What is the all time high quarterly CFO for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly cash flow from operations is -$2.74M
What is Edgewise Therapeutics quarterly CFO year-on-year change?
Over the past year, EWTX quarterly cash flow from operations has changed by -$9.27M (-32.41%)
What is Edgewise Therapeutics TTM cash flow from operations?
The current TTM CFO of EWTX is -$118.30M
What is the all time high TTM CFO for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM cash flow from operations is -$2.74M
What is Edgewise Therapeutics TTM CFO year-on-year change?
Over the past year, EWTX TTM cash flow from operations has changed by -$20.58M (-21.06%)